Human Genome Epidemiology Literature Finder
|
Records 1 - 26 (of 26 Records) |
| Query Trace: Thrombosis and ABCB1[original query] |
|---|
| A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2008 May 111 (9): 4496-9. French Deborah, Hamilton Leo H, Mattano Leonard A, Sather Harland N, Devidas Meenakshi, Nachman James B, Relling Mary V, |
| CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study. European heart journal 2010 Dec 31 (24): 3046-53. Harmsze Ankie M, van Werkum Jochem W, Ten Berg Jurriën M, Zwart Bastiaan, Bouman Heleen J, Breet Nicoline J, van 't Hof Arnoud W J, Ruven Hendrik J T, Hackeng Christian M, Klungel Olaf H, de Boer Anthonius, Deneer Vera H |
| Predicting clopidogrel response using DNA samples linked to an electronic health record. Clinical pharmacology and therapeutics 2011 Dec . Delaney JT, Ramirez AH, Bowton E, Pulley JM, Basford MA, Schildcrout JS, Shi Y, Zink R, Oetjens M, Xu H, Cleator JH, Jahangir E, Ritchie MD, Masys DR, Roden DM, Crawford DC, Denny JC |
| Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction. International journal of cardiology 2013 Sep 167 (6): 2882-8. Verschuren Jeffrey J W, Boden Helèn, Wessels Judith A M, van der Hoeven Bas L, Trompet Stella, Heijmans Bastiaan T, Putter Hein, Guchelaar Henk-Jan, Schalij Martin J, Jukema J Wout |
| CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: is clinical testing helpful? Indian heart journal 2012 64 (4): 4. Singh M, Shah T, Adigopula S, Molnar J, Ahmed A, Khosla S, Arora R |
| Paraoxonase-1 is not a major determinant of stent thrombosis in a Taiwanese population. PloS one 2012 7 (6): e39178. Chen Dong-Yi, Wang Chao-Yung, Wen Ming-Shien, Lee Tsong-Hai, Chu Yen, Hsieh Ming-Jer, Chang Shang-Hung, Lee Cheng-Hung, Wang Jian-Liang, Chen Chun-Chi, Lu Laing-Suei, Lee Ming-Ta, Yeh San-Jou, Lin Fun-Chiung, Hsieh I-Cha |
| Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study. Journal of the American College of Cardiology 2012 May 59 (22): 1928-37. Price Matthew J, Murray Sarah S, Angiolillo Dominick J, Lillie Elizabeth, Smith Erin N, Tisch Rebecca L, Schork Nicholas J, Teirstein Paul S, Topol Eric J, |
| No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting. Circulation. Cardiovascular interventions 2012 Feb 5 (1): 82-8, S1-2. Jaitner Juliane, Morath Tanja, Byrne Robert A, Braun Siegmund, Gebhard Daniela, Bernlochner Isabell, Schulz Stefanie, Mehilli Julinda, Schömig Albert, Koch Werner, Kastrati Adnan, Sibbing Di |
| Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention. European journal of clinical pharmacology 2012 Nov . Tang XF, Wang J, Zhang JH, Meng XM, Xu B, Qiao SB, Wu YJ, Chen J, Wu Y, Chen JL, Gao RL, Yuan JQ, Yang YJ |
| ABCB1 C3435T polymorphism and risk of adverse clinical events in clopidogrel treated patients: a meta-analysis. Thrombosis research 2012 Jun 129 (6): 754-9. Luo Man, Li Jiaoxing, Xu Xiaowei, Sun Xunsha, Sheng Wen |
| The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2013 Jul 9 (3): 316-27. Liang Zhen-Yang, Han Ya-Ling, Zhang Xiao-Lin, Li Yi, Yan Cheng-Hui, Kang Ji |
| Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC. Cardiovascular interventions 2013 Nov 6 (11): 11. Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G |
| The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease. Pharmacogenetics and genomics 2014 Apr 24 (4): 204-10. Xie Cheng, Ding Xiaoliang, Gao Jie, Wang Haipeng, Hang Yongfu, Zhang Hua, Zhang Jingjing, Jiang Bin, Miao Liy |
| Genetic polymorphisms of CYP2C19 2 and ABCB1 C3435T affect the pharmacokinetic and pharmacodynamic responses to clopidogrel in 401 patients with acute coronary syndrome. Gene 2015 Mar 558 (2): 200-7. Wang Xia-Qin, Shen Chen-Lin, Wang Bang-Ning, Huang Xiao-Hui, Hu Zhang-le, Li J |
| Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme. European heart journal 2015 Nov . Puymirat Etienne, Lamhaut Lionel, Bonnet Nicolas, Aissaoui Nadia, Henry Patrick, Cayla Guillaume, Cattan Simon, Steg Gabriel, Mock Laurent, Ducrocq Gregory, Goldstein Patrick, Schiele François, Bonnefoy-Cudraz Eric, Simon Tabassome, Danchin Nicol |
| Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin. Journal of thrombosis and haemostasis : JTH 2016 Nov . Gouin-Thibault I, Delavenne X, Blanchard A, Siguret V, Salem J E, Narjoz C, Gaussem P, Beaune P, Funck-Brentano C, Azizi M, Mismetti P, Loriot M |
| Impact of ABCB1 and CYP2D6 polymorphisms on tamoxifen treatment outcomes and adverse events in breast cancer patients. Journal of B.U.ON. : official journal of the Balkan Union of Oncology 0 22 (5): 1217-1226. Argalacsova Sona, Slanar Ondrej, Bakhouche Hana, Pertuzelka Lub |
| Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? Pharmacogenomics and personalized medicine 2017 10 10 243-245. Rytkin Eric, Mirzaev Karin B, Grishina Elena A, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Giliarov Michael Iu, Andreev Denis A, Sychev Dmitriy |
| The CYP2C19*2 and CYP2C19*17 Polymorphisms play a Vital Role in Clopidogrel Responsiveness after Percutaneous Coronary Intervention: A Pharmacogenomics Study. Basic & clinical pharmacology & toxicology 2017 Jan . Saydam Faruk, De?irmenci ?rfan, Birdane Alparslan, Özdemir Mahmut, Ulus Taner, Özbayer Cansu, Çolak Ertu?rul, Ata Necmi, Güne? Hasan Vey |
| Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention. Cardiovascular toxicology 2018 May . Mahdieh Nejat, Rabbani Ahmad, Firouzi Ata, Zahedmehr Ali, Hoseinimoghaddam Maryam, Saedi Sedigheh, Sanati Hamidreza, Basiri Hosseinali, Noohi Feridoun, Rabbani Bahareh, Maleki Maj |
| Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort. Pharmacogenomics 2018 12 20 (2): 75-83. Melin Kyle, Moon Jee-Young, Qi Qibin, Hernandez-Suarez Dagmar F, Duconge Jorge, Hua Simin, Gonzalez Sara, Zeng Donglin, Kaplan Robert |
| Effects of genetic variants on platelet reactivity and one-year clinical outcomes after percutaneous coronary intervention: A prospective multicentre registry study. Scientific reports 2018 1 8 (1): 1229. Joo Hyung Joon, Ahn Sung Gyun, Park Jae Hyoung, Park Ji Young, Hong Soon Jun, Kim Seok-Yeon, Choi WoongGil, Gwon HyeonCheol, Lim Young-Hyo, Kim Weon, Kang Woong Chol, Cho Yun-Hyeong, Kim Yong Hoon, Yoon JungHan, Shin WonYong, Hong Myeong-Ki, Garg Scot, Jang Yangsoo, Lim Do-S |
| Multiplate evaluation of acetylsalicylic acid efficacy in carotid surgery: routine and genetic influencing factors. Journal of thrombosis and haemostasis : JTH 2018 Jan . Roullet S, Labrouche S, Carrie C, Auque H, Berard X, Freyburger |
| Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention. Iranian journal of pharmaceutical research : IJPR 2020 19 (2): 307-316. Namazi Soha, Sahebi Ebrahim, Azarpira Negar, Rostami-Yalmeh Javad, Kojuri Javad, Khalili And |
| Profiling of warfarin pharmacokinetics-associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics-dosing algorithm. Journal of thrombosis and haemostasis : JTH 2021 Aug . Ndadza Arinao, Muyambo Sarudzai, Mntla Pindile, Wonkam Ambroise, Chimusa Emile, Kengne Andre P, Ntsekhe Mpiko, Dandara Coll |
| Rivaroxaban for Thromboembolism Prophylaxis in Patients with Nephrotic Syndrome: A Single-Arm, Prospective Study. Kidney diseases (Basel, Switzerland) 2024 10 10 (5): 346-358. Meng Wei, Xue Wu, Liteng Wang, Zhichun Gu, Yuanmao Tu, Lihua Zhang, Jiong Zhang, Honglang Xie, Qing Zhou, Yanan Chu, Zhen Cheng, Guohua Zhou, Qinxin So |
- Page last reviewed:Feb 1, 2024
- Content source: